Sovereign Capital Partners

Results Healthcare Advises Sovereign Capital Partners on its Investment in Bioscript

Results Healthcare is delighted to announce that it has advised leading UK private equity firm Sovereign Capital Partners on its significant investment in Bioscript, an independent medical communications agency serving international pharmaceutical, biotechnology and medical device companies.

Established in 2005, Bioscript is an international provider of medical communications and regulatory writing services for pharmaceutical companies. Headquartered in the UK and with a team of almost 100, Bioscript assists clients in their communications with regulatory authorities as well as educating the medical sector on pharmaceutical products that are in mid to late-stage clinical trials and subsequently supporting these products, post-market launch, to maintain and grow sales throughout the lifecycle of the drug.

Results, with a team led by David Sanders and Murelli Sooriyakumar, served as financial adviser to Sovereign Capital Partners.

This transaction highlights the value of Results Healthcare’s sector knowledge to private equity bidders and cements the firm’s expertise in the healthcare communications sector, following deals including the sale of Cormis Partners to Huntsworth, Unlimited Health’s US division to Next15 and 2e Creative to Fishawack.